BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/31/2016 7:20:00 PM | Browse: 557 | Download: 671
Publication Name World Journal of Obstetrics and Gynecology
Manuscript ID 22301
Country/Territory Canada
2015-08-25 13:41
Peer-Review Started
2015-08-28 19:45
To Make the First Decision
2015-11-06 11:08
Return for Revision
2015-11-10 10:09
2015-11-11 00:01
Second Decision
2015-12-02 13:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-12-11 16:56
Articles in Press
2015-12-11 16:56
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-01-23 20:37
Publish the Manuscript Online
2016-01-31 19:20
ISSN 2218-6220 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Pathobiological role of MUC16 mucin (CA125) in ovarian cancer: Much more than a tumor biomarker
Manuscript Source Invited Manuscript
All Author List Alain Piché
Funding Agency and Grant Number
Funding Agency Grant Number
Internal Funding from Université de Sherbrooke
Corresponding author Alain Piché, MD, Département de Microbiologie et Infectiologie, Faculté de Médecine, Université de Sherbrooke, 3001, 12ième Avenue Nord, Sherbrooke J1H 5N1, Canada. alain.piche@usherbrooke.ca
Key Words MUC16; CA125; Mucin; Ovarian cancer; Tumorigenesis; Biomarker
Core Tip MUC16/CA125 has been a mainstay biomarker for ovarian cancer but its pathobiological role has remained mostly unknown. Recent literature has shown that MUC16 is much more than a biomarker. MUC16 has oncogenic properties and plays an important role in tumorigenesis. Here, we will review the current knowledge regarding the oncogenic role of MUC16.
Publish Date 2016-01-31 19:20
Citation Piché A. Pathobiological role of MUC16 mucin (CA125) in ovarian cancer: Much more than a tumor biomarker. World J Obstet Gynecol 2016; 5(1): 39-49
Url http://www.wjgnet.com/2218-6220/full/v5/i1/39.htm
DOI http://dx.doi.org/10.5317/wjog.v5.i1.39
Full Article (PDF) WJOG-5-39.pdf
Full Article (Word) WJOG-5-39.doc
Manuscript File 22301-Review.docx
Answering Reviewers 22301-Answering reviewers.pdf
Audio Core Tip 22301-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 22301-Conflict-of-interest statement.pdf
Copyright License Agreement 22301-Copyright assignment.pdf
Peer-review Report 22301-Peer-review(s).pdf
Scientific Misconduct Check 22301-Scientific misconduct check.pdf
Scientific Editor Work List 22301-Scientific editor work list.pdf